Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concentrate: a 7-day observational study of trauma patients

Overview of attention for article published in Critical Care, July 2014

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 96 Dimensions

Readers on

mendeley: 49 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 8 X posts from 6 X users, with an upper bound of 9,339 followers.

RT @J_Stensballe: @thomas1973 @karimbrohi Overdose yes in that way no evidence support this yet😎, but not overdosis acc to Austria/Swiss ap…

22 Mar 2019

Reply Repost Favourite

@thomas1973 @karimbrohi Overdose yes in that way no evidence support this yet😎, but not overdosis acc to Austria/Swiss approach where this is used, see more here (fromAustria🇦🇹🇦🇹🇦🇹) https://t.co/X7XYtyyWSs

22 Mar 2019

Reply Repost Favourite

@macky_neal @bhwords @bryanacotton1 @dfaraoni @NATAforum Yes, both adenexa and idarucizumap are very poorly studied in bleeding and coagulopathic pts, in trauma I would be concerned about the increased thrombin potential for several days after PCC - random

06 May 2018

Reply Repost Favourite

RT @J_Stensballe: PCC in trauma? Schoschl: ETP to HIGH👎 https://t.co/0tpa0ynFfP @HBuMoore @macky_neal @bellaljosephMD @docmartin22 @bryanac…

25 Feb 2017

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.